AU2003216869A1 - Nucleic acid molecules involved in the synthesis of melithiazols - Google Patents
Nucleic acid molecules involved in the synthesis of melithiazolsInfo
- Publication number
- AU2003216869A1 AU2003216869A1 AU2003216869A AU2003216869A AU2003216869A1 AU 2003216869 A1 AU2003216869 A1 AU 2003216869A1 AU 2003216869 A AU2003216869 A AU 2003216869A AU 2003216869 A AU2003216869 A AU 2003216869A AU 2003216869 A1 AU2003216869 A1 AU 2003216869A1
- Authority
- AU
- Australia
- Prior art keywords
- melithiazols
- synthesis
- nucleic acid
- acid molecules
- molecules involved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/167—Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02006389 | 2002-03-21 | ||
EP02006389.7 | 2002-03-21 | ||
PCT/EP2003/002987 WO2003080828A2 (en) | 2002-03-21 | 2003-03-21 | Nucleic acid molecules involved in the synthesis of melithiazols |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003216869A1 true AU2003216869A1 (en) | 2003-10-08 |
AU2003216869A8 AU2003216869A8 (en) | 2003-10-08 |
Family
ID=28051726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003216869A Abandoned AU2003216869A1 (en) | 2002-03-21 | 2003-03-21 | Nucleic acid molecules involved in the synthesis of melithiazols |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1520025A2 (en) |
AU (1) | AU2003216869A1 (en) |
WO (1) | WO2003080828A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0909743D0 (en) | 2009-06-05 | 2009-07-22 | F2G Ltd | Antifungal targgt |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4410449C2 (en) * | 1994-03-25 | 2003-02-20 | Biotechnolog Forschung Gmbh | Melithiazoles A and B, manufacturing process, agents containing Melithiazol A and / or B and Melittangium lichenicola DSM 9004 with the ability to form Melithiazole A and B. |
CA2352451C (en) * | 2001-07-24 | 2003-04-08 | Ecopia Biosciences Inc. | High throughput method for discovery of gene clusters |
-
2003
- 2003-03-21 AU AU2003216869A patent/AU2003216869A1/en not_active Abandoned
- 2003-03-21 EP EP03712074A patent/EP1520025A2/en not_active Ceased
- 2003-03-21 WO PCT/EP2003/002987 patent/WO2003080828A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003080828A2 (en) | 2003-10-02 |
WO2003080828A3 (en) | 2003-11-27 |
AU2003216869A8 (en) | 2003-10-08 |
EP1520025A2 (en) | 2005-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL233352A0 (en) | Rna molecules and pharmaceutical compositions containing the same and uses thereof | |
AU2003900368A0 (en) | Assay for nucleic acid molecules | |
AU2003228627A1 (en) | Application of cantilevers in nucleic acid sequencing | |
AU2003288304A1 (en) | Novel molecules derived from noraporphine | |
EP1664298A4 (en) | Modified gene-silencing nucleic acid molecules and uses thereof | |
AU2003230957A1 (en) | Quantitation of biological molecules | |
AU2003238772A1 (en) | In vitro evaluation of nucleic acid ligands | |
AU2003240436A1 (en) | Microarrays displaying encoded molecules | |
AU2003250506A1 (en) | Method for the characterisation of nucleic acid molecules | |
AU2003303588A1 (en) | Methods and compositions for sequencing nucleic acid molecules | |
AU2003285489A1 (en) | Nucleic acid ligands and uses therefor | |
AU2003273995A1 (en) | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites | |
EP1572168A3 (en) | Anti-infarction molecules | |
AU2003232036A1 (en) | Nanoarchaeum nucleic acid molecule | |
AU2003210629A1 (en) | Methods for the integrated synthesis and purification of oligonucleotides | |
AU2003216869A1 (en) | Nucleic acid molecules involved in the synthesis of melithiazols | |
EP1614750A4 (en) | Novel functional peptide nucleic acid and process for producing the same | |
AU2003238443A1 (en) | Separation of molecules | |
AU2003255804A1 (en) | Comparison of molecules using field points | |
AU2003270143A1 (en) | Improved methods for the synthesis of nucleic acids | |
EP1497306A4 (en) | Alternatively spliced nucleic acid molecules | |
AU2003212825A1 (en) | Aggrecanase molecules | |
AU2003290332A1 (en) | Identification of single molecules | |
AU2002952545A0 (en) | Nucleic acid molecules | |
AU2002950956A0 (en) | Nucleic acid molecule and uses therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |